BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29198134)

  • 1. If We Build It, Will They Come? Perceptions of HIV Cure-Related Research by People Living with HIV in Four U.S. Cities: A Qualitative Focus Group Study.
    Sylla L; Evans D; Taylor J; Gilbertson A; Palm D; Auerbach JD; Dubé K
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):56-66. PubMed ID: 29198134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States.
    Dubé K; Taylor J; Sylla L; Evans D; Dee L; Burton A; Willenberg L; Rennie S; Skinner A; Tucker JD; Weiner BJ; Greene SB
    PLoS One; 2017; 12(1):e0170112. PubMed ID: 28122027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy.
    Dubé K; Eskaf S; Evans D; Sauceda J; Saberi P; Brown B; Averitt D; Martel K; Meija M; Campbell D; Barr L; Kanazawa J; Perry K; Patel H; Luter S; Poteat T; Auerbach JD; Wohl DA
    AIDS Res Hum Retroviruses; 2020 Apr; 36(4):324-348. PubMed ID: 31608651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of HIV Virologic Control Strategies Among Younger and Older Age Groups of People Living with HIV in the United States: A Cross-Sectional Survey.
    Saberi P; Eskaf S; Sauceda J; Evans D; Dubé K
    AIDS Res Hum Retroviruses; 2020 Jul; 36(7):606-615. PubMed ID: 32368934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options.
    Dubé K; Campbell DM; Perry KE; Kanazawa JT; Saberi P; Sauceda JA; Poteat T; Evans D
    AIDS Res Hum Retroviruses; 2020 Dec; 36(12):1054-1058. PubMed ID: 32829645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry.
    Dubé K; Evans D; Dee L; Sylla L; Taylor J; Skinner A; Weiner BJ; Greene SB; Rennie S; Tucker JD
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):67-79. PubMed ID: 28562069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of Risks and Benefits of Participating in HIV Cure-Related Research Among Diverse Young Adults Living with HIV in the United States: Qualitative Research Findings.
    Saberi P; Campbell CK; Sauceda JA; Ndukwe S; Dubé K
    AIDS Res Hum Retroviruses; 2022 Aug; 38(8):649-659. PubMed ID: 35579937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical activity levels among Malawian adults living with HIV and receiving anti-retroviral therapy.
    Chisati EM; Munthali F; Constantinou D; Lampiao F
    Malawi Med J; 2020 Mar; 32(1):8-12. PubMed ID: 32733653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of HIV cure research among people living with HIV in Australia.
    Power J; Westle A; Dowsett GW; Lucke J; Tucker JD; Sugarman J; Lewin SR; Hill S; Brown G; Wallace J; Richmond J
    PLoS One; 2018; 13(8):e0202647. PubMed ID: 30142171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deterrents to HIV-patient initiation of antiretroviral therapy in urban Lusaka, Zambia: a qualitative study.
    Musheke M; Bond V; Merten S
    AIDS Patient Care STDS; 2013 Apr; 27(4):231-41. PubMed ID: 23530573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "I Know That I Was a Part of Making a Difference": Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption.
    Neergaard R; Jones NL; Roebuck C; Rendle KA; Barbati Z; Peterson B; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dube K; Barg FK
    AIDS Res Hum Retroviruses; 2023 Aug; 39(8):414-421. PubMed ID: 35979886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
    Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
    MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States.
    Dubé K; Kanazawa J; Patel H; Louella M; Sylla L; Sheehy J; Dee L; Taylor J; Adair J; Anthony-Gonda K; Dropulić B; Sauceda JA; Peluso MJ; Deeks SG; Simoni J
    BMC Med Ethics; 2022 Apr; 23(1):39. PubMed ID: 35397551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of alcohol and drugs in the view of people living with HIV/AIDS: a qualitative study.
    Oliveira Serra MAA; Araújo E Silva R; Beserra EP; Melo TN; Sousa LV; Araújo MFM
    Public Health; 2017 Aug; 149():99-105. PubMed ID: 28582690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions of Equipoise, Risk-Benefit Ratios, and "Otherwise Healthy Volunteers" in the Context of Early-Phase HIV Cure Research in the United States: A Qualitative Inquiry.
    Dubé K; Dee L; Evans D; Sylla L; Taylor J; Brown B; Miller V; Corneli A; Skinner A; Greene SB; Tucker JD; Rennie S
    J Empir Res Hum Res Ethics; 2018 Feb; 13(1):3-17. PubMed ID: 28984168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication.
    Fridman I; Ubel PA; Blumenthal-Barby J; England CV; Currier JS; Eyal N; Freedberg KA; Halpern SD; Kelley CF; Kuritzkes DR; Le CN; Lennox JL; Pollak KI; Zikmund-Fisher BJ; Scherr KA
    AIDS Behav; 2020 Jul; 24(7):2054-2061. PubMed ID: 31900813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "It is not that I forget, it's just that I don't want other people to know": barriers to and strategies for adherence to antiretroviral therapy among HIV patients in Northern Vietnam.
    Van Tam V; Pharris A; Thorson A; Alfven T; Larsson M
    AIDS Care; 2011 Feb; 23(2):139-45. PubMed ID: 21259125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "How am I going to live?": exploring barriers to ART adherence among adolescents and young adults living with HIV in Uganda.
    MacCarthy S; Saya U; Samba C; Birungi J; Okoboi S; Linnemayr S
    BMC Public Health; 2018 Oct; 18(1):1158. PubMed ID: 30286746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the cultural context of HIV stigma on antiretroviral therapy adherence among people living with HIV/AIDS in southwest Nigeria.
    Okoror TA; Falade CO; Olorunlana A; Walker EM; Okareh OT
    AIDS Patient Care STDS; 2013 Jan; 27(1):55-64. PubMed ID: 23305262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of Cell and Gene Therapy for Curing HIV Infection Among People Living with HIV in the Northwestern United States: A Qualitative Study.
    Dubé K; Simoni J; Louella M; Sylla L; Mohamed ZH; Patel H; Luter S; Collier AC
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):649-659. PubMed ID: 30990052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.